Interleukin-6 inhibitors reduce mortality in coronavirus disease-2019: An individual patient data meta-analysis from randomized controlled trials

OBJECTIVE: To assess the efficacy of IL-6 inhibitors compared to standard of care (SOC) in COVID-19 patients. DATA SOURCES: A systematic review of the MEDLINE and Scopus databases (last search: October 8(th), 2021) was performed according to the PRISMA statement. STUDY SELECTION: Randomized control...

Descripción completa

Detalles Bibliográficos
Autores principales: Tasoudis, Panagiotis T., Arvaniti, Christina K., Adamou, Anastasia T., Belios, Ioannis, Stone, John H., Horick, Nora, Sagris, Dimitrios, Dalekos, George N., Ntaios, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Federation of Internal Medicine. Published by Elsevier B.V. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986475/
https://www.ncbi.nlm.nih.gov/pubmed/35422374
http://dx.doi.org/10.1016/j.ejim.2022.04.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986475/
https://www.ncbi.nlm.nih.gov/pubmed/35422374
http://dx.doi.org/10.1016/j.ejim.2022.04.004

Ejemplares similares